BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33686920)

  • 1. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection.
    Chen W; Chen S; Huang Y
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):411-426. PubMed ID: 33686920
    [No Abstract]   [Full Text] [Related]  

  • 2. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes.
    Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y
    Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.
    Rex DK; Bhandari R; Lorch DG; Meyers M; Schippers F; Bernstein D
    Dig Liver Dis; 2021 Jan; 53(1):94-101. PubMed ID: 33243567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remimazolam: First Approval.
    Keam SJ
    Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Application and Research Progress of Remimazolam for Pediatric Patients.
    Bai C; Xu M; Guo Y; Jin Y; Zhao X
    Drug Des Devel Ther; 2024; 18():1221-1229. PubMed ID: 38645987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials.
    Pesic M; Stöhr T; Ossig J; Borkett K; Donsbach M; Dao VA; Webster L; Schippers F
    Drugs R D; 2020 Sep; 20(3):267-277. PubMed ID: 32757149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remimazolam: A Retrospective Study of Initial Safety and Recovery Data in Diverse Procedural Sedation.
    Johnson KL; Meyers JS; Mortensen GN; Steege JR; Mara KC; Brinkman NJ
    Clin Ther; 2024 Feb; 46(2):90-95. PubMed ID: 38071132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.
    Kim KM
    Anesth Pain Med (Seoul); 2022 Jan; 17(1):1-11. PubMed ID: 35139608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
    Rogers WK; McDowell TS
    IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remimazolam for anaesthesia or sedation.
    Sneyd JR; Rigby-Jones AE
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice.
    Masui K
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):344-351. PubMed ID: 38841907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.
    Morimoto Y
    Ther Clin Risk Manag; 2022; 18():95-100. PubMed ID: 35140469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.